Search Results
The inside story behind the approval of the gene therapy drug Glybera
Public release date: 30-May-2013 [ | E-mail | Share ] Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 x2156 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, May 15, 2013The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. In addition, an in-depth Review reveals the inside story of the European regulatory review and approval of Glybera, chock full of twists and turn, politics, and intrigue, reviews and critiques the groundbreaking drug's path to the marketplace appears in in Human Gene Therapy Clinical Development